Literature DB >> 24827603

Myocardial perfusion imaging for predicting cardiac events in Japanese patients with advanced chronic kidney disease: 1-year interim report of the J-ACCESS 3 investigation.

Nobuhiko Joki1, Hiroki Hase, Yuhei Kawano, Satoko Nakamura, Kenichi Nakajima, Tsuguru Hatta, Shigeyuki Nishimura, Masao Moroi, Susumu Nakagawa, Tokuo Kasai, Hideo Kusuoka, Yasuchika Takeishi, Mitsuru Momose, Kazuya Takehana, Mamoru Nanasato, Shunichi Yoda, Hidetaka Nishina, Naoya Matsumoto, Tsunehiko Nishimura.   

Abstract

PURPOSE: Whether myocardial perfusion imaging (MPI) can predict cardiac events in patients with advanced conservative chronic kidney disease (CKD) remains unclear.
METHODS: The present multicenter prospective cohort study aimed to clarify the ability of MPI to predict cardiac events in 529 patients with CKD and estimated glomerular filtration rates (eGFR) < 50 ml/min per 1.73(2) without a definitive diagnosis of coronary artery disease. All patients were assessed by stress-rest MPI with (99m)Tc-tetrofosmin and analyzed using summed defect scores and QGS software. Cardiac events were analyzed 1 year after registration.
RESULTS: Myocardial perfusion abnormalities defined as summed stress score (SSS) ≥4 and ≥8 were identified in 19 and 7 % of patients, respectively. At the end of the 1-year follow-up, 33 (6.2 %) cardiac events had occurred that included cardiac death, sudden death, nonfatal myocardial infarction, and hospitalization due to heart failure. The event-free rates at that time were 0.95, 0.90, and 0.81 for groups with SSS 0-3, 4-7, and ≥8, respectively (p = 0.0009). Thus, patients with abnormal SSS had a higher incidence of cardiac events. Multivariate Cox regression analysis showed that SSS significantly impacts the prediction of cardiac events independently of eGFR and left ventricular ejection fraction.
CONCLUSION: MPI would be useful to stratify patients with advanced conservative CKD who are at high risk of cardiac events without adversely affecting damaged kidneys.

Entities:  

Mesh:

Year:  2014        PMID: 24827603     DOI: 10.1007/s00259-014-2781-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  31 in total

1.  Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin.

Authors:  A Levin; C R Thompson; J Ethier; E J Carlisle; S Tobe; D Mendelssohn; E Burgess; K Jindal; B Barrett; J Singer; O Djurdjev
Journal:  Am J Kidney Dis       Date:  1999-07       Impact factor: 8.860

Review 2.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

3.  Cardiac event risk in Japanese subjects estimated using gated myocardial perfusion imaging, in conjunction with diabetes mellitus and chronic kidney disease.

Authors:  Kenichi Nakajima; Shinro Matsuo; Chio Okuyama; Tsuguru Hatta; Kazumasa Tsukamoto; Shigeyuki Nishimura; Akira Yamashina; Hideo Kusuoka; Tsunehiko Nishimura
Journal:  Circ J       Date:  2011-11-19       Impact factor: 2.993

Review 4.  Should we screen for coronary artery disease in asymptomatic chronic dialysis patients?

Authors:  An S De Vriese; Stefaan J Vandecasteele; Barbara Van den Bergh; Frank W De Geeter
Journal:  Kidney Int       Date:  2011-09-28       Impact factor: 10.612

5.  Prognostic study of cardiac and renal events in Japanese patients with chronic kidney disease and cardiovascular risk using myocardial perfusion SPECT: J-ACCESS 3 study design.

Authors:  Satoko Nakamura; Yuhei Kawano; Hiroki Hase; Tsuguru Hatta; Shigeyuki Nishimura; Masao Moroi; Susumu Nakagawa; Tokuo Kasai; Hideo Kusuoka; Yasuchika Takeishi; Kenichi Nakajima; Mitsuru Momose; Kazuya Takehana; Mamoru Nanasato; Syunichi Yoda; Hidetaka Nishina; Naoya Matsumoto; Tsunehiko Nishimura
Journal:  Ther Apher Dial       Date:  2010-08-01       Impact factor: 1.762

6.  Inter-institution preference-based variability of ejection fraction and volumes using quantitative gated SPECT with 99mTc-tetrofosmin: a multicentre study involving 106 hospitals.

Authors:  Kenichi Nakajima; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-29       Impact factor: 9.236

7.  Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  David A Goodkin; Jennifer L Bragg-Gresham; Karl G Koenig; Robert A Wolfe; Takashi Akiba; Vittorio E Andreucci; Akira Saito; Hugh C Rayner; Kiyoshi Kurokawa; Friedrich K Port; Philip J Held; Eric W Young
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

8.  Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study.

Authors:  Yoshihiro Kokubo; Satoko Nakamura; Tomonori Okamura; Yasunao Yoshimasa; Hisashi Makino; Makoto Watanabe; Aya Higashiyama; Kei Kamide; Katsuyuki Kawanishi; Akira Okayama; Yuhei Kawano
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

Review 10.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

View more
  7 in total

1.  Impact of non-invasive cardiovascular screening programs as a predictor of cardiovascular events among asymptomatic chronic kidney disease patients.

Authors:  Akihiro Sawai; Yoshinari Yasuda; Susumu Suzuki; Hideki Ishii; Motomitsu Goto; Sawako Kato; Mutsuharu Hayashi; Shoichi Maruyama; Toyoaki Murohara; Yutaka Oiso; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2015-09-24       Impact factor: 2.801

2.  Risk stratification based on J-ACCESS risk models with myocardial perfusion imaging: Risk versus outcomes of patients with chronic kidney disease.

Authors:  Kenichi Nakajima; Satoko Nakamura; Hiroki Hase; Yasuchika Takeishi; Shigeyuki Nishimura; Yuhei Kawano; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2018-06-12       Impact factor: 5.952

3.  Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese patients with chronic kidney disease: a study based on the J-ACCESS-3 database.

Authors:  Shinro Matsuo; Kenichi Nakajima; Yasuchika Takeishi; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-03       Impact factor: 9.236

4.  Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis.

Authors:  Amjad M Ahmed; Waqas T Qureshi; Wesley T O'Neal; Fatima Khalid; Mouaz H Al-Mallah
Journal:  J Nucl Cardiol       Date:  2017-01-03       Impact factor: 5.952

5.  Impact of renal dysfunction on the choice of diagnostic imaging, treatment strategy, and outcomes in patients with stable angina.

Authors:  Takao Kato; Yukari Uemura; Masanao Naya; Mitsuru Momose; Naoya Matsumoto; Eriko Suzuki; Satoshi Hida; Takatomo Nakajima; Takao Yamauchi; Nagara Tamaki
Journal:  Sci Rep       Date:  2019-05-27       Impact factor: 4.379

Review 6.  Myocardial Ischemia Assessment in Chronic Kidney Disease: Challenges and Pitfalls.

Authors:  Susie F C Parnham; Jonathan M Gleadle; Carmine G De Pasquale; Joseph B Selvanayagam
Journal:  Front Cardiovasc Med       Date:  2014-12-19

7.  Prognostic study of cardiac events in Japanese patients with chronic kidney disease using ECG-gated myocardial Perfusion imaging: Final 3-year report of the J-ACCESS 3 study.

Authors:  Satoko Nakamura; Yuhei Kawano; Kenichi Nakajima; Hiroki Hase; Nobuhiko Joki; Tsuguru Hatta; Shigeyuki Nishimura; Masao Moroi; Susumu Nakagawa; Tokuo Kasai; Hideo Kusuoka; Yasuchika Takeishi; Mitsuru Momose; Kazuya Takehana; Mamoru Nanasato; Syunichi Yoda; Hidetaka Nishina; Naoya Matsumoto; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2017-04-24       Impact factor: 5.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.